Lexeo Therapeutics Inc (LXEO)

Cost of Revenue

$546.00K

TTM · Period ending: · USD

LXEO logo

LXEO Cost of Revenue

Latest reported$546.00K
LXEO TTM Cost of Revenue ($6.70K → $546.00K)
High-resolution chart · PNG

LXEO cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lexeo Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
546,000
546,000
0
0
0
0
0
0
0
0
0
0
0
0
6,702
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.